Blood Transfusion Diagnostics Market Share, Size, Trends, Industry Analysis Report, By Product (Instruments, Reagents & Kits, Others); By Application; By End-Use; By Region; Segment Forecast, 2024 - 2032
- Published Date:Jan-2024
- Pages: 117
- Format: PDF
- Report ID: PM1316
- Base Year: 2023
- Historical Data: 2019 – 2022
Report Outlook
The global blood transfusion diagnostics market was valued at USD 4.21 billion in 2023 and is expected to grow at a CAGR of 5.3% during the forecast period.
Blood transfusion diagnostics is the process of testing blood and its components prior to its administration to patients. Each unit of blood is tested for both blood group typing and disease screening prior to transfusion. This critical process aims to reduce the possibility of adverse reactions or infection transmission. It is critical in transfusion therapy, providing vital information to healthcare professionals and ensuring the compatibility of donor and recipient blood samples.
Several factors are driving the growth of the blood transfusion diagnostics market. The global market for blood and blood components is expanding rapidly, owing to increased demand from trauma and accident cases. Advances in blood transfusion diagnostic technology, particularly the improvement of precise and accurate instruments, have contributed to an increase in demand for these products. Major market players are actively developing technologically advanced solutions that are available at competitive prices, leading to greater adoption of blood transfusion diagnostics.
To Understand More About this Research: Request a Free Sample Report
- For instance, according to data published by the National Cancer Institute, almost 490,875 individuals in the United States were reported to be undergoing leukemia in the year 2020.
The rising prevalence of blood-related disorders is the primary driver of the blood transfusion market's expansion. There has been a significant increase in the number of people undergoing blood loss as a result of various issues and chronic illnesses over the last decade. Blood loss is caused by a variety of chronic conditions, including but not limited to cancer, hemophilia, and renal disease. Furthermore, the rise in severe infections, liver disorders, and other medical conditions causes the occurrence of significant blood loss.
The pandemic of COVID-19 has had a significant impact on the blood transfusion diagnosis market. On one side, the increased demand for blood products as a result of the virus and its complications has highlighted the importance of strong diagnostic tools to ensure transfusion safety. On the other side, disruptions in healthcare services, supply chain issues, and the diversion of resources to fight the pandemic, have created challenges for the blood transfusion diagnostics sector. In the midst of the pandemic, the need for rapid and precise diagnostic solutions has become even more critical, driving innovation and technological advancements in the market. Despite the challenges, the increased focus on healthcare and the need to address emerging infectious threats contribute to the growth of the market.
The research report offers a quantitative and qualitative analysis of the Blood Transfusion Diagnostics Market to enable effective decision-making. It covers the key trends and growth opportunities anticipated to have a favorable impact on the market. Besides, the study covers segment and regional revenue forecasts for market assessment.
Increased occurrences of injuries and fatalities as a result of traffic accidents are anticipated to drive the blood transfusion market. Road traffic accidents are a major public health concern, accounting for the majority of global fatalities and injuries. Such incidents frequently result in serious injuries that necessitate immediate medical attention, including blood transfusions. The rising number of traffic accidents and injuries is anticipated to increase the demand for blood, boosting the growth of the blood transfusion market.
Industry Dynamics
Growth Drivers
- Improvements in the diagnostic technologies will drive the growth of the market
The betterment in the diagnostic technologies will drive the growth of the market in the forecast period. The evolution of advanced tests and systems that provide greater precision, faster results, and increased automation has transformed the field of blood transfusion diagnostics. For instance, the incorporation of NAT techniques, such as polymerase chain reaction (PCR) and real-time PCR, has transformed the identification of infectious agents in donated blood.
These molecular-based techniques have high sensitivity and specificity, allowing pathogens to be identified quickly and reducing the risk of transfusion-related infections. Also, the incorporation of automation and robotics into laboratory workflows has optimized laboratory workflows, resulting in increased capacity and efficiency in blood transfusion diagnostics. The continuous advancement of technology maintains the market's growth by providing healthcare practitioners with dependable and effective tools to ensure the safety of blood transfusions.
Report Segmentation
The market is primarily segmented based on product, application, end-use, and region.
|
By Product |
By Application |
By End-Use |
By Region |
|
|
|
|
To Understand the Scope of this Report: Speak to Analyst
By Product Analysis
- The reagent & kits segment accounted for the largest revenue share
The reagent & kits segment held the largest revenue share. The easy availability of products and frequent purchases highlight the importance of screening both donor and recipient samples, serving as a significant catalyst for the growth of this segment. Furthermore, the proliferation of a donor screening reagents typing, and wide range of blood grouping, assays, and kits introduced by both global and local entities contributes to the growth of the market.
The increasing risk of Transfusion-Transmitted Infections (TTIs) has driven donor screening demand. The increasing risk necessitates stringent screening to prevent the transmission of contaminated blood and blood products, thereby addressing the TTI challenge. The easy accessibility and widespread availability of sophisticated donor analyzers are driving the growth of the market.
By Application Analysis
- The disease screening segment accounted for the highest market share during the forecast period
The disease screening segment held the highest market share during the forecast period, improving the significance of disease screening has become critical in order to prevent the spread of infections. The risk of blood transfusions is the spread of infections within the recipient's body. To ensure the safety of donated blood, thorough disease screening for transfusion purposes is essential.
Furthermore, the rising prevalence of blood-related diseases has increased the demand for blood transfusions. This increased need for transfusions increases the risk of transfusion-transmitted diseases like Hepatitis B and HIV-1, which may deteriorate a patient's health. As a result, there is a growing need for thorough screening of donors prior to blood transfusions, particularly in less developed countries where the prevalence of these diseases is higher.
Regional Insights
- North America accounted for the largest market share
North America held the largest market share in the blood transfusion diagnostics market. owing to the presence of prominent key companies in the region and the widespread adoption of cutting-edge healthcare technology. Furthermore, blood transfusion market in north america is anticipated to expand in revenue due to the rising prevalence of chronic diseases and the increasing number of medical procedures.
Raising blood donation awareness, ensuring easy access to testing facilities, and involving both international and key players are anticipated to drive market expansion in this region. As per the American Red Cross, about 16 million blood components are transfused in the United States each year. The surging demand for these blood components is likely to drive demand for blood transfusion diagnostics.
Asia Pacific is witnessed for the fastest growth in the blood transfusion diagnostics market. The increased demand for blood transfusion diagnostics in emerging markets such as India and China are anticipated to drive market growth. The increase is attributed to an increasing demand for blood transfusions, which has been fueled by an increase in medical procedures and a high prevalence of chronic illnesses. Increased investments in healthcare infrastructure and the adoption of innovative diagnostic technologies are substantial contributors to the market's growth in the region.
Key Market Players & Competitive Insights
The market is characterized by intense competition, with established players relying on advanced technology, high-quality products, and a strong brand image to drive revenue growth. These companies employ various strategies such as research and development, mergers and acquisitions, and technological innovations to expand their product portfolios and maintain a competitive edge in the market.
Some of the major players operating in the global market include:
- Abbott Laboratories
- Bio-Rad Laboratories, Inc.
- Diamond Diagnostics
- Diagnostica Stago
- Electro Medical Technologies
- F. Hoffmann-La Roche Ltd
- Grifols S.A.
- Immucor Inc.
- Ortho Clinical Diagnostics
- Quotient Ltd.
Recent Developments
- In May 2021, Ortho Clinical Diagnostics has launched the ORTHO VISION Swift and ORTHO VISION Max Swift Analyzers, that offer improved blood transfusion diagnostics. These analyzers provide laboratories with increased processing power, increased responsiveness, and advanced data security, ensuring quick, accurate, and dependable test results.
- In March 2021, Bio-Rad Laboratories, Inc. has partnered with Roche to deliver InteliQ products Unity QC data management solutions to a global customer base. These innovative products and solutions encompass a diverse array of spanning immunoassay, blood screening functionalities, immunology, cardiac assessment, chemistry, diabetes, coagulation, and more.
Blood Transfusion Diagnostics Market Report Scope
|
Report Attributes |
Details |
|
Market size value in 2024 |
USD 4.42 billion |
|
Revenue forecast in 2032 |
USD 6.66 billion |
|
CAGR |
5.3% from 2024 – 2032 |
|
Base year |
2023 |
|
Historical data |
2019 – 2022 |
|
Forecast period |
2024 – 2032 |
|
Quantitative units |
Revenue in USD billion and CAGR from 2024 to 2032 |
|
Segments Covered |
By Product, By Application, By End-Use, By Region |
|
Regional scope |
North America, Europe, Asia Pacific, Latin America; Middle East & Africa |
|
Customization |
Report customization as per your requirements with respect to countries, region and segmentation |
We strive to offer our clients the finest in market research with the most reliable and accurate research findings. We use industry-standard methodologies to offer a comprehensive and authentic analysis of the Blood Transfusion Diagnostics Market. Besides, we have stringent data-quality checks in place to enable data-driven decision-making for you.
Browse Our More Top Selling Reports:
Non-Invasive Prenatal Testing (Nipt) Market Size & Share
Dental Laboratory Welders Market Size & Share
Molecular Quality Controls Market Size & Share
FAQ's
The blood transfusion diagnostics market report covering key segments are product, application, end-use, and region.
Blood Transfusion Diagnostics Market Size Worth $6.66 Billion By 2032
The global blood transfusion diagnostics market is expected to grow at a CAGR of 5.3% during the forecast period.
North America is leading the global market
key driving factors in blood transfusion diagnostics market are 1. Improvements in the diagnostic technologies will drive the growth of the market
